Industry Overview - The demand for eyeglass frames in China is increasing due to rising income levels and changing consumer preferences, leading to higher expectations for quality, design, and functionality [1][11] - In the first five months of 2025, the import value of eyeglass frames reached 660 million yuan, a year-on-year increase of 7.3%, while the export value was 4.782 billion yuan, a year-on-year decrease of 4.43% [1][11] - The trend of consumption upgrading is driving consumers to prefer international brands, lightweight materials (such as pure titanium and carbon fiber), and functional frames (like smart glasses and sports protective frames) [1][11] - The global eyewear market is experiencing slower growth, impacting the eyeglass frame market, but high-value products like smart and customized frames are seeing growth, indicating a shift from "scale expansion" to "value enhancement" in the industry [1][11] Industry Development History - The Chinese eyeglass frame industry has evolved through four main stages: the embryonic stage (1950s-1970s), growth stage (1980s-1990s), rapid development (2000-2010), and full competition (2010-present) [4][5] - The industry began with handmade production and limited product variety, transitioning to a more diverse and quality-focused market with the introduction of foreign brands and new materials [4][5] - Technological advancements have significantly improved materials, design, and functionality, enabling domestic companies to compete with international brands [4][5] Industry Chain - The upstream of the eyeglass frame industry includes raw materials (metal and non-metal materials) and production equipment, while the midstream focuses on manufacturing [8] - The downstream primarily serves the eyewear industry, indicating a well-structured supply chain [8] Current Industry Status - The eyeglass frame industry is characterized by a mix of diversified and concentrated competition, with leading companies and emerging brands shaping the market dynamics [13] - Notable companies include LUXOTTICA, which offers a wide range of products, and domestic firms like Zhongshan Tuokai Optical, focusing on high-cost performance products [13] Key Companies' Performance - Companies like Wanxin Optical and Hengfa Optical are significant players in the industry, with Wanxin being a leading manufacturer in Asia and Hengfa focusing on precision manufacturing and rapid response capabilities [14][15] - Wanxin Optical has a production capacity of over 3.5 million frames annually and exports to nearly 40 countries, while Hengfa Optical has a strong presence in the European market [14][15] Industry Development Trends - The industry is witnessing a shift towards smart and multifunctional products driven by technological innovation, with products like AR glasses gaining traction [17] - Consumer preferences are evolving towards personalized and high-end products, with companies offering customization services to enhance brand loyalty [19] - The global competitiveness of the Chinese eyeglass frame industry is increasing, with exports reaching 30.441 billion yuan in 2024, indicating a transition from "OEM export" to "brand expansion" [20]

Investment Rating - The report maintains a positive outlook on the smart glasses industry, indicating a robust growth trajectory and recommending attention to key players such as 康耐特光学, 明月镜片, 博士眼镜, and 英派斯 [5][31]. Core Insights - The smart glasses market is experiencing rapid growth, driven by the introduction of AI and AR glasses, with significant potential for long-term expansion [2][6]. - The industry is at a pivotal point where traditional eyewear is evolving, and midstream lens manufacturing and downstream eyewear channels remain crucial [3][7]. - The report highlights the increasing integration of advanced functionalities in smart glasses, which enhances user interaction and expands application scenarios [18][19]. Summary by Sections 1. Smart Glasses: AI and AR Glasses Flourishing - AI glasses, exemplified by Meta's RayBan Meta, have ignited market interest, with significant sales growth expected [24][29]. - AR glasses are evolving with continuous optical solution iterations, broadening their application scope [6][18]. - The market is witnessing a surge in domestic players, with companies like 雷鸟创新, Xreal, and Rokid rapidly developing their product lines [4][6]. 2. Transformation of Traditional Eyewear - The midstream lens manufacturing sector is seeing steady global demand growth, with a shift towards higher-value, functional products [4][7]. - Downstream channels, particularly offline retail, play a vital role in capturing consumer trends and facilitating product development [9][7]. - The report emphasizes the importance of collaboration between smart glasses manufacturers and established eyewear retailers to enhance market penetration [9][7]. 3. Key Companies to Watch - 康耐特光学 is positioned as a leading lens manufacturer, focusing on domestic market growth and XR business opportunities [5][31]. - 明月镜片 is enhancing its product structure and actively engaging in high-growth segments like AI glasses [5][31]. - 博士眼镜 is expanding its retail presence and integrating smart glasses into its service offerings [5][31]. - 英派斯 is diversifying into the AI glasses sector while maintaining steady growth in its core fitness equipment business [5][31].

Core Viewpoint - The stock price of Mingyue Lens (301101.SZ) surged by 10% on June 23, reflecting strong market interest, particularly in the context of AI-related products and smart glasses [1][2]. Company Performance - Mingyue Lens has seen its stock price double over the past year, driven by its positioning as a key player in the AI glasses market [1][2]. - The company reported a net profit of 47.15 million yuan in Q1, marking an 11.70% year-on-year increase, with total revenue reaching 197 million yuan, a 2.63% increase [5][6]. - From 2021 to 2024, the company has consistently achieved revenue and net profit growth, with revenues of 5.76 billion yuan in 2021 and projected 7.70 billion yuan in 2024, reflecting a compound annual growth rate [7][8]. Market Position - Mingyue Lens is recognized as a leading domestic optical lens manufacturer, holding a 12.4% market share in the Chinese lens market as of 2024, and has been the top-selling brand for nine consecutive years [11][12]. - The company has established a strong international presence, with products sold in the US, Japan, Italy, and Singapore, and has set up an international business headquarters in Singapore [3][12]. Financial Health - The company has maintained a stable gross margin above 50% since 2019, with a projected gross margin of 58.56% for 2024 and 58.42% in Q1 of this year [3][9]. - The net profit margin has also shown significant improvement, increasing from 8.21% in 2018 to 24.40% in 2024, with a Q1 net profit margin of 25.13% [10]. Shareholder Returns - Mingyue Lens has actively returned value to shareholders, distributing a total of 272 million yuan in dividends over four years, with an average dividend payout ratio of 45.37% [4]. Innovation and R&D - The company has invested in R&D, collaborating with renowned optical experts and establishing a technology center, leading to several patented innovations in lens technology [12][13]. - Mingyue Lens has developed advanced materials and products, including the KR ultra-tough lens and PMC ultra-bright lens, enhancing its competitive edge in the market [12][13]. Strategic Focus - The company is strategically positioning itself in the AI glasses market, engaging with 3C brands for customized lens solutions, which is expected to drive future growth [13].

Investment Rating - The report maintains an "Outperform" rating for the company [1] Core Insights - The company is focusing on building an eye health industry ecosystem, with significant advancements in defocus lenses and AI glasses, indicating strong growth potential in these high-potential segments [6] - The company showcased its clinical results for the "Light Control Pro 2.0," which demonstrated significant effectiveness in controlling myopia progression, suggesting a competitive edge in the defocus lens market [6] - The company plans to develop a comprehensive eye health industrial park to enhance its brand and production capabilities, which is expected to drive future growth [6] - The report highlights the company's commitment to high-end differentiation in traditional lenses while actively pursuing opportunities in the AI glasses market, positioning it well for future growth [6] Financial Data and Profit Forecast - Projected total revenue for 2025 is 854 million, with a year-on-year growth rate of 10.9% [5] - Expected net profit attributable to the parent company for 2025 is 207 million, reflecting a year-on-year growth of 16.9% [5] - The report forecasts a gross margin of 60.3% for 2025, indicating a positive trend in profitability [5] - The company is expected to achieve a return on equity (ROE) of 11.0% in 2025, with a projected PE ratio of 46 [5]

Core Viewpoint - Mingyue Lens is entering a new strategic phase, emphasizing innovation and commitment to visual health, while leveraging its brand ambassador, Olympic diving champion Guo Jingjing, to enhance brand recognition and social responsibility in youth myopia management [1][3][9]. Group 1: Brand Development and Strategy - Mingyue Lens has evolved from a "hidden champion" focused on technology research to the leading domestic lens brand in market share, driven by innovation in product iteration, technological breakthroughs, and market expansion [3]. - The company has committed to investing approximately 150 million yuan in research and development over the past five years, with a projected investment of no less than 300 million yuan in the next five years, aiming for at least 5% of sales revenue [5]. - Mingyue Lens aims to establish itself as a technology-driven company, emphasizing the importance of protecting visual health for Chinese consumers [5]. Group 2: Product Innovation and Market Position - Mingyue Lens has introduced innovative products such as the Easy Control, PMC Ultra Bright, and high-index thin series lenses, catering to diverse consumer needs [5]. - The company has achieved significant technological advancements, including self-developed 1.71 refractive index lenses and pioneering 3D internal engraving technology [13]. - Clinical research indicates that the Easy Control Pro 2.0 lens effectively slows myopia progression with an efficacy rate of 73.82% [15]. Group 3: Partnerships and Collaborations - Mingyue Lens has signed a cooperation agreement with the Jenvis Innovation Research Center at Jena University, aiming to integrate strengths in optical technology research and accelerate internationalization [17]. - The collaboration is expected to enhance Mingyue Lens's position as a representative brand in the optical field on the international stage [17]. Group 4: Social Responsibility and Awareness - The partnership with Guo Jingjing aims to raise awareness about youth myopia management, with initiatives like the Youth Vision Care Program launched during the brand event [9]. - Mingyue Lens emphasizes the importance of social responsibility in addressing the severe issue of myopia among youth, aligning its brand mission with public health goals [9][15].

Group 1 - Mingyue Optical Lens has launched an innovative eye health industrial park plan, integrating R&D, production, and experiential learning [1] - The company is the only listed firm in A-shares focusing on optical resin lenses, with a product range including lenses, raw materials, and frames [1] - The core products are mid-to-high-end optical resin lenses, primarily marketed under the "Mingyue" brand [1] Group 2 - Starting in 2024, Mingyue Optical Lens will also venture into AI smart glasses, emphasizing the importance of lens quality for user experience [2] - The company plans to invest at least 300 million yuan in R&D over the next five years, with a minimum of 5% of sales revenue allocated to R&D [2] - Innovations include self-developed lenses with a refractive index of 1.71 and the use of 3D internal engraving technology [2] Group 3 - Traditional optical imaging faces issues like pixel blur and color distortion, which can be addressed by computational optical imaging platforms [3] - Computational optics combines traditional optics with computer graphics and AI deep learning, enhancing image resolution significantly [3] - AI can enable high-resolution dynamic imaging, allowing for advanced 3D holographic information retrieval without prior knowledge of object positioning [3]

本公司及董事会全体成员保证公告内容与信息披露义务人提供的信息一 致。 2025 年 5 月 19 日，公司在巨潮资讯网（www.cninfo.com.cn）披露了《关 于实际控制人及其一致行动人、董事兼高级管理人员、持股 5%以上股东减持股 份的预披露公告》（公告编号：2025-015）。持有公司 12,667,564 股的股东诺 伟其拟于该公告披露之日起 15 个交易日后的 3 个月内（即 2025 年 6 月 11 日至 2025 年 9 月 10 日），通过集中竞价及大宗交易方式合计减持公司股份不超过 3,000,000 股，即不超过剔除公司回购专用账户股份数量后总股本的 1.4945%。 其中：通过集中竞价方式减持股份比例不超过剔除公司回购专用账户股份数量后 总股本的 1%；通过大宗交易方式减持股份比例不超过剔除公司回购专用账户股 份数量后总股本的 2%。 公司近日收到持股 5%以上股东诺伟其出具的《关于减持明月镜片股份触及 1%整数倍的告知函》，获悉其于 2025 年 6 月 11 日至 2025 年 6 月 16 日期间，诺 伟其通过证券交易所集中竞价交易方式合计减持公司股份 655,200 股， ...

证券代码：301101 证券简称：明月镜片 公告编号：2025-017 明月镜片股份有限公司 关于注销部分募集资金专项账户的公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚 假记载、误导性陈述或重大遗漏。 一、募集资金基本情况 经中国证券监督管理委员会《关于同意明月镜片股份有限公司首次公开发行 股票注册的批复》（证监许可〔2021〕3473 号）同意注册，公司获准首次公开发 行人民币普通股（A 股）股票 3,358.54 万股，每股面值 1 元，每股发行价格为 人民币 26.91 元，募集资金总额为人民币 903,783,114.00 元，扣除各类发行费 用后实际募集资金净额为人民币 792,923,877.64 元。上述募集资金到位情况经 立信会计师事务所（特殊普通合伙）进行了审验，并于 2021 年 12 月 13 日出具 了"信会师报字[2021]第 ZA15935 号"《验资报告》。 公司已将上述募集资金存放于募集资金专项账户，并与保荐机构、存放募集 资金的商业银行签署了《募集资金监管协议》。 二、募集资金存放与管理情况 为了规范募集资金的管理和使用，保护投资者权益，公司已按照《 ...

Core Insights - The domestic lens company Mingyue is transitioning from a follower to a leader in the industry, showcasing significant advancements in myopia management lenses [1][2] - The clinical trial results for Mingyue's "Easy Control" lenses demonstrate a high efficacy rate of 73.82% in slowing myopia progression, indicating a substantial impact on eye health for adolescents [1] - Mingyue's commitment to R&D and understanding of Chinese children's eye habits has led to innovative lens designs that balance effective prevention and good visual experience [1][2] Company Developments - Mingyue has broken the long-standing monopoly of Japanese and Korean companies in the raw materials market for lenses through independent research and development [2] - The company has introduced several leading resin lens products, including the 1.71 series and dual anti-blue light lenses, which have been validated in national projects [2] - Mingyue not only utilizes its high-quality materials but also shares them with other domestic manufacturers, promoting the overall upgrade of the local lens industry [2] Brand Positioning - Mingyue has appointed Olympic diving champion Guo Jingjing as its brand ambassador, marking a significant milestone in its brand evolution [3] - The company holds a market share of 12.4% in lens retail volume for 2024, maintaining its position as the leading domestic lens brand for nine consecutive years [5] - The presence of Guo Jingjing wearing Mingyue lenses on international platforms symbolizes a shift in perception of "Made in China" towards higher quality and stronger brand recognition [5] Product Innovation - Mingyue has developed a unique lens design that caters to the specific eye movement patterns of Chinese children, enhancing comfort and adaptability [6] - The "Easy Control" lenses utilize advanced resin materials, offering better clarity and visual performance compared to traditional PC materials, thus redefining the standards for myopia control lenses [6] - The innovative design and material choice of Mingyue's lenses ensure effective clinical outcomes and a user-friendly experience for children [6]

Core Viewpoint - The announcement reveals plans for significant share reductions by major shareholders and executives of Mingyue Lens, indicating potential changes in ownership dynamics and investor sentiment towards the company [1][2][3] Group 1: Shareholder Reductions - The controlling shareholder, Shanghai Mingyue Industrial Co., Ltd., and its actual controllers plan to reduce their holdings by up to 6,000,000 shares, representing 2.9891% of the total share capital excluding repurchased shares, within a three-month period from June 11 to September 10, 2025 [1] - The board member and deputy general manager, Zeng Zhe, intends to reduce his holdings by up to 800,000 shares, which is 24.4312% of his total shares, equating to 0.3985% of the total share capital excluding repurchased shares [2] - Shareholder Nuo Wei Qi plans to reduce his holdings by up to 3,000,000 shares, representing 1.4945% of the total share capital excluding repurchased shares [2] Group 2: Shareholder Relationships - The actual controllers, Xie Gongwan, Xie Gongxing, and Zeng Shaohua, are related, with Xie Gongwan and Xie Gongxing being brothers and Zeng Shaohua being Xie Gongwan's sister's spouse; they collectively hold 100% of Shanghai Mingyue [3] - The relationship among the shareholders indicates a coordinated approach to share reduction, as they are considered acting in concert [3] Group 3: Company Background - Mingyue Lens was listed on the Shenzhen Stock Exchange's Growth Enterprise Market on December 16, 2021, with an initial public offering of 33.5854 million shares at a price of 26.91 yuan per share [3] - The total funds raised from the IPO amounted to 904 million yuan, with a net amount of 793 million yuan after deducting issuance costs, exceeding the original plan by 225 million yuan [3] - The funds raised are intended for various projects, including high-end resin lens expansion, conventional resin lens expansion and technology upgrades, research center construction, and marketing network development [3]